Cargando…

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees

BACKGROUND: Experimental human immunodeficiency virus (HIV)-1 vaccines frequently elicit antibodies against HIV-1 that may react with commonly used HIV diagnostic tests, a phenomenon known as vaccine-induced seropositivity/seroreactivity (VISP/VISR). We sought to determine, under clinic conditions,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oganezova, Karina, Fontana-Martinez, Elvin J, Gothing, Jon A, Pandit, Alisha, Kwara, Esther, Yanosick, Katherine, Dragavon, Joan, Goecker, Erin A, Maenza, Janine, Espy, Nicole, Tomaka, Frank, Lavreys, Ludo, Allen, Mary, D’Souza, Patricia, Hural, John, Coombs, Robert W, Dolin, Raphael, Seaman, Michael S, Walsh, Stephen R, Baden, Lindsey R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813203/ https://www.ncbi.nlm.nih.gov/pubmed/33511233 http://dx.doi.org/10.1093/ofid/ofaa606

Ejemplares similares

The Influence of Poststudy Action Congruency on Memory Consolidation
por: Zeelenberg, René, et al.
Publicado: (2020)

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants
por: Espy, Nicole, et al.
Publicado: (2023)

Patient perspectives on Peyronie’s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum
por: Kaminetsky, J., et al.
Publicado: (2018)

Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
por: Orrell, Catherine, et al.
Publicado: (2015)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees
por: Caini, Saverio, et al.
Publicado: (2021)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Les taux de personnes vaccinées et non vaccinées contre le COVID-19 en France. Comparaison des indicateurs en open data et tentative d'estimation
por: Geay, C., et al.
Publicado: (2023)

Ability of History Taking Alone to Identify Early Pregnancies Among Potential Measles Vaccinees
por: Mead, Philip B.
Publicado: (1994)

Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees
por: Mateus, Jose, et al.
Publicado: (2020)

Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines
por: Flasche, Stefan, et al.
Publicado: (2019)

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
por: Garziano, Micaela, et al.
Publicado: (2022)

Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees
por: Asperti, Chiara, et al.
Publicado: (2022)

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine
por: Haritay, Shivani, et al.
Publicado: (2023)

996. CD4+ T-Cell Lymphopenia Associated with Frequent Plateletpheresis in Healthy Donors
por: Cunningham, Phoebe H, et al.
Publicado: (2021)

Week 48 results of a Phase IV trial of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected treatment-experienced adults
por: Arathoon, Eduardo, et al.
Publicado: (2014)

Low rate of seropositivity (IgG) to mumps component in MMR vaccinees in Chennai, south India
por: Malaiyan, Jeevan, et al.
Publicado: (2014)

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
por: Martinez, David R., et al.
Publicado: (2020)

High viral loads: what drives fatal cases of COVID-19 in vaccinees? – an autopsy study
por: Hirschbühl, Klaus, et al.
Publicado: (2022)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
por: Anichini, Gabriele, et al.
Publicado: (2022)

Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees
por: Choi, Ickwon, et al.
Publicado: (2015)

Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees
por: Hudu, S. A., et al.
Publicado: (2015)

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
por: Yates, Nicole L., et al.
Publicado: (2018)

A Systematic, Unbiased Mapping of CD8(+) and CD4(+) T Cell Epitopes in Yellow Fever Vaccinees
por: Stryhn, Anette, et al.
Publicado: (2020)

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022)

Virus-induced breath biomarkers: A new perspective to study the metabolic responses of COVID-19 vaccinees
por: Cen, Zhengnan, et al.
Publicado: (2023)

Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial
por: Arathoon, Eduardo, et al.
Publicado: (2017)

Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
por: Zolla-Pazner, Susan, et al.
Publicado: (2013)

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
por: Peng, Qiaoli, et al.
Publicado: (2022)

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
por: Wang, Kang, et al.
Publicado: (2022)

Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees
por: Wu, Minghui, et al.
Publicado: (2022)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
por: Zhu, Yuqi, et al.
Publicado: (2022)

Screening Vaccinees for Non-Communicable Diseases and Risk Factors at a Covid-19 Vaccination Center in Vadodara, Gujarat
por: Chavda, Paragkumar D., et al.
Publicado: (2022)

A Nationwide Survey of mRNA COVID-19 Vaccinee’s Experiences on Adverse Events and Its Associated Factors
por: Yoon, Dongwon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qjsoh0htdrksi8fshalli8caao